{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:06:03Z","timestamp":1790024763655,"version":"4.0.1"},"reference-count":25,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.9388","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T09:26:57Z","timestamp":1536053217000},"source":"Crossref","is-referenced-by-count":5,"title":["Histone deacetylase inhibitors sensitize 5\u2011fluorouracil\u2011resistant MDA\u2011MB\u2011468 breast cancer cells to 5\u2011fluorouracil"],"prefix":"10.3892","author":[{"given":"Tetsuya","family":"Minegaki","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Tsuzuki","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Tsunoda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Tsujimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohshi","family":"Nishiguchi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University, Kyoto 607\u20118414, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"key20200714084406_b1-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1349-7006.2001.tb01068.x","article-title":"High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro","volume":"92","author":"Habara","year":"2001","journal-title":"Jpn J Cancer Res"},{"key":"key20200714084406_b2-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.oraloncology.2008.04.010","article-title":"The role of dihydropyrimidine dehydrogenase expression in resistance to 5-fluorouracil in head and neck squamous cell carcinoma cells","volume":"45","author":"Yasumatsu","year":"2009","journal-title":"Oral Oncol"},{"key":"key20200714084406_b3-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1158\/1535-7163.MCT-04-0291","article-title":"The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites","volume":"4","author":"Pratt","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"key20200714084406_b4-ol-0-0-9388","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int J Mol Sci"},{"key":"key20200714084406_b5-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejphar.2016.12.001","article-title":"Histone acetylation and histone deacetylation in neuropathic pain: An unresolved puzzle?","volume":"795","author":"Khangura","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"key20200714084406_b6-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"e0174107","DOI":"10.1371\/journal.pone.0174107","article-title":"The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia","volume":"12","author":"Rauzan","year":"2017","journal-title":"PLoS One"},{"key":"key20200714084406_b7-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.lungcan.2016.11.019","article-title":"Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat","volume":"103","author":"To","year":"2017","journal-title":"Lung Cancer"},{"key":"key20200714084406_b8-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ijc.24403","article-title":"Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells","volume":"125","author":"Fazzone","year":"2009","journal-title":"Int J Cancer"},{"key":"key20200714084406_b9-ol-0-0-9388","first-page":"563","article-title":"Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines","volume":"16","author":"Zhang","year":"2006","journal-title":"Oncol Rep"},{"key":"key20200714084406_b10-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00432-004-0664-6","article-title":"The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells","volume":"131","author":"Ocker","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20200714084406_b11-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/dote.12370","article-title":"Effects of bisphosphonates on human esophageal squamous cell carcinoma cell survival","volume":"29","author":"Minegaki","year":"2016","journal-title":"Dis Esophagus"},{"key":"key20200714084406_b12-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1248\/bpb.25.771","article-title":"Cytotoxic effects of 27 anticancer drugs in HeLa and MDR1-overexpressing derivative cell lines","volume":"25","author":"Takara","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"key20200714084406_b13-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10549-014-3017-4","article-title":"Tamoxifen through GPER upregulates aromatase expression: A novel mechanism sustaining tamoxifen-resistant breast cancer cell growth","volume":"146","author":"Catalano","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"key20200714084406_b14-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1349-7006.2003.tb01495.x","article-title":"Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil: A study of 88 surgical specimens","volume":"94","author":"Yoshinare","year":"2003","journal-title":"Cancer Sci"},{"key":"key20200714084406_b15-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/sj.bjc.6604211","article-title":"Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer","volume":"98","author":"Matsubara","year":"2008","journal-title":"Br J Cancer"},{"key":"key20200714084406_b16-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/ijc.23852","article-title":"Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes","volume":"124","author":"Gustavsson","year":"2009","journal-title":"Int J Cancer"},{"key":"key20200714084406_b17-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200714084406_b18-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3892\/ol.2012.1014","article-title":"Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin","volume":"5","author":"Minegaki","year":"2013","journal-title":"Oncol Lett"},{"key":"key20200714084406_b19-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000098110","article-title":"Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil","volume":"70","author":"Ciaparrone","year":"2006","journal-title":"Oncology"},{"key":"key20200714084406_b20-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/cancers2031717","article-title":"5-fu metabolism in cancer and orally-administrable 5-fu drugs","volume":"2","author":"Miura","year":"2010","journal-title":"Cancers (Basel)"},{"key":"key20200714084406_b21-ol-0-0-9388","first-page":"1545","article-title":"Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line","volume":"20","author":"Tsutani","year":"2008","journal-title":"Oncol Rep"},{"key":"key20200714084406_b22-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.lungcan.2005.05.003","article-title":"The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells","volume":"49","author":"Oguri","year":"2005","journal-title":"Lung Cancer"},{"key":"key20200714084406_b23-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/ijc.11221","article-title":"Overexpression of thymidylate synthase mediates desensitization for 5-fluorouracil of tumor cells","volume":"106","author":"Saga","year":"2003","journal-title":"Int J Cancer"},{"key":"key20200714084406_b24-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00280-006-0384-5","article-title":"Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: Thymidylate synthase dependent and independent networks","volume":"59","author":"Wang","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20200714084406_b25-ol-0-0-9388","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2008.12.033","article-title":"Molecular changes to HeLa cells on continuous exposure to SN-38, an active metabolite of irinotecan hydrochloride","volume":"278","author":"Takara","year":"2009","journal-title":"Cancer Lett"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:42:54Z","timestamp":1594719774000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.9388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.9388","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]}}}